Just my thoughts here.. but wouldn't it make sense for a larger pharm. company like say, johnson & johnson( who gave icagen 15mm in up-front $$ for the development of their sickle cell drug..which has been canceled) to look for other "stronger" candidates ..like xkem?? if nicosan truely has no real competition then it would be a no brainer for pfe/jnj/bmy etc etc to approach xkem with some type of partnership..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.